Correction: Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma

Correction: Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma

Bibliographic Details
Main Authors:	Xiaoge Gao, Pin Jiang, Qian Zhang, Qian Liu, Shuangshuang Jiang, Ling Liu, Maomao Guo, Qian Cheng, Junnian Zheng, Hong Yao
Format:	Article
Language:	English
Published:	BMC 2023-04-01
Series:	Journal of Experimental & Clinical Cancer Research
Online Access:	https://doi.org/10.1186/s13046-023-02669-2

Similar Items

Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma
by: Xiaoge Gao, et al.
Published: (2019-08-01)

A novel PH1/pE27HGFK1 nanoparticles for orthotopic glioblastoma therapy
by: Jian zhang, et al.
Published: (2024-06-01)

HGFK1 Enhances the Anti-Tumor Effects of Angiogenesis Inhibitors via Inhibition of CD90+ CSCs in Hepatocellular Carcinoma
by: Tao Li, et al.
Published: (2024-05-01)

Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma
by: Haisu Tao, et al.
Published: (2023-03-01)

Multiple Roles of Autophagy in the Sorafenib Resistance of Hepatocellular Carcinoma
by: Ting Sun, et al.
Published: (2017-11-01)

Targeted regulation of autophagy using sorafenib-loaded biomineralization nanoenzyme for enhanced photodynamic therapy of hepatoma
by: Tianming Lu, et al.
Published: (2024-12-01)

Effects of Sorafenib and Arsenic Trioxide on U937 and KG-1 Cell Lines: Apoptosis or Autophagy?
by: Atousa Haghi, et al.
Published: (2020-10-01)

Autophagy and biotransformation affect sorafenib resistance in hepatocellular carcinoma
by: Ruiqi Zheng, et al.
Published: (2023-01-01)

Oxidative Stress Activated by Sorafenib Alters the Temozolomide Sensitivity of Human Glioma Cells Through Autophagy and JAK2/STAT3-AIF Axis
by: Jianwei Wei, et al.
Published: (2021-06-01)

Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
by: Leyi Yao, et al.
Published: (2022-07-01)

The current status of tumor microenvironment and cancer stem cells in sorafenib resistance of hepatocellular carcinoma
by: Siqi Chen, et al.
Published: (2023-07-01)

Autophagy modulation attenuates sorafenib resistance in HCC induced in rats
by: Yomna Elleithi, et al.
Published: (2024-08-01)

Remodeling Serine Synthesis and Metabolism via Nanoparticles (NPs)‐Mediated CFL1 Silencing to Enhance the Sensitivity of Hepatocellular Carcinoma to Sorafenib
by: Senlin Li, et al.
Published: (2023-07-01)

Decitabine Enhances Sorafenib Sensitivity in Renal Cell Carcinoma by Promoting BIN1 and SYNE1 Expressions
by: Lijie Kang, et al.
Published: (2024-10-01)

Cadmium promotes ferroptosis in renal tubular epithelial cells by inducing autophagy
by: LI Min, et al.
Published: (2022-09-01)

Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
by: Xinye Qian, MD, PhD
Published: (2023-03-01)

Plk1 promotes renal tubulointerstitial fibrosis by targeting autophagy/lysosome axis
by: Yang Du, et al.
Published: (2023-08-01)

Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib
by: Ning Zheng, et al.
Published: (2019-05-01)

CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma
by: Bowen Li, et al.
Published: (2021-08-01)

Effect of sorafenib induced apoptosis and autophagy on drug resistance in HeLa cells
by: YANG Kaifei, ZHU Jingge, ZHANG Yangyang, ZHAO Junguo, GAO Yuyue, HU Huanhuan, JI Guojie
Published: (2024-04-01)

Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma
by: Danyang Li, et al.
Published: (2022-03-01)

Experience with sorafenib in the treatment of advanced renal cell carcinoma
by: Giuseppe Procopio, et al.
Published: (2012-12-01)

Knockdown of lncRNA TP53TG1 Enhances the Efficacy of Sorafenib in Human Hepatocellular Carcinoma Cells
by: Qingchun Lu, et al.
Published: (2022-08-01)

Efficacy of cryoablation combined with sorafenib for the treatment of advanced renal cell carcinoma
by: Changfu Liu, et al.
Published: (2019-01-01)

Focused Ultrasound Enhances Brain Delivery of Sorafenib Nanoparticles
by: Daniel Dahis, et al.
Published: (2023-02-01)

Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation
by: Hong-Yue Lai, et al.
Published: (2021-01-01)

Loss of TACC1 variant25 inducing cell proliferation and suppressing autophagy in head and neck squamous carcinoma
by: Pan Xu, et al.
Published: (2021-12-01)

Identification of Sorafenib as a Treatment for Type 1 Diabetes
by: Qin Zeng, et al.
Published: (2022-02-01)

The Role of Bcl-2 and Beclin-1 Complex in “Switching” between Apoptosis and Autophagy in Human Glioma Cells upon LY294002 and Sorafenib Treatment
by: Adrian Zając, et al.
Published: (2023-11-01)

A comprehensive review of the relationship between autophagy and sorafenib-resistance in hepatocellular carcinoma: ferroptosis is noteworthy
by: Kangnan Zhang, et al.
Published: (2023-04-01)

The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma
by: Qu Xu-Dong, et al.
Published: (2012-06-01)

Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma
by: Ryu Sasaki, MD, PhD, et al.
Published: (2022-05-01)

GINS1 Induced Sorafenib Resistance by Promoting Cancer Stem Properties in Human Hepatocellular Cancer Cells
by: Sheng Li, et al.
Published: (2021-08-01)

Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights
by: Xinchen Tian, et al.
Published: (2022-08-01)

Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma
by: Xiaolong Tang, et al.
Published: (2018-01-01)

Sorafenib Inhibits Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Inhibition of Macrophage Infiltration
by: Wenting Ma, et al.
Published: (2016-10-01)

Overendocytosis of gold nanoparticles increases autophagy and apoptosis in hypoxic human renal proximal tubular cells
by: Ding F, et al.
Published: (2014-09-01)

GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma
by: Shiwen Ma, et al.
Published: (2024-12-01)

Sorafenib-Loaded Nanoparticles Based on Biodegradable Dendritic Polymers for Enhanced Therapy of Hepatocellular Carcinoma
by: Li Z, et al.
Published: (2020-03-01)

Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
by: Zhi Zeng, et al.
Published: (2021-07-01)